ASH-AABB Joint Session: Current Clinical Trials for Transfusion Therapy for Thrombocytopenic Patients and Relevant Issues
Program Code: 106-S
Saturday, October 23, 2004
10:30 AM to 12:00 PM (ET)

SPEAKERS
Scott Murphy, MD, American Red Cross Blood Services
Sherrill J. Slichter, MD, Puget Sound Blood Center
Kathryn Webert, MD, Hamilton Regional Laboratory Medicine Program

DESCRIPTION
This session provides a review of the protocol for the multi-center, randomized, controlled clinical trial sponsored by the Transfusion Medicine/Hemostasis Clinical Trials Network and the National Heart, Lung and Blood Institute (NHLBI): Determination of the optimal prophylactic platelet dose strategy to prevent bleeding in thrombocytopenic patients. Also included is a description of the multi-center, randomized, controlled clinical trial sponsored by Canadian Blood Services: The effect of maintaining an increased hemoglobin concentration on the frequency of bleeding in thrombocytopenic patients. Lastly, the standards for the storage of human platelets will be reviewed.

AUDIENCE
Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, Perfusionists

PROGRAM LEVEL
Advanced